These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30459441)

  • 1. Metabolomics and transcriptomics pathway approach reveals outcome-specific perturbations in COPD.
    Cruickshank-Quinn CI; Jacobson S; Hughes G; Powell RL; Petrache I; Kechris K; Bowler R; Reisdorph N
    Sci Rep; 2018 Nov; 8(1):17132. PubMed ID: 30459441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying a gene expression signature of frequent COPD exacerbations in peripheral blood using network methods.
    Morrow JD; Qiu W; Chhabra D; Rennard SI; Belloni P; Belousov A; Pillai SG; Hersh CP
    BMC Med Genomics; 2015 Jan; 8():1. PubMed ID: 25582225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes.
    Bowler RP; Jacobson S; Cruickshank C; Hughes GJ; Siska C; Ory DS; Petrache I; Schaffer JE; Reisdorph N; Kechris K
    Am J Respir Crit Care Med; 2015 Feb; 191(3):275-84. PubMed ID: 25494452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot analysis of the plasma metabolite profiles associated with emphysematous Chronic Obstructive Pulmonary Disease phenotype.
    Paige M; Burdick MD; Kim S; Xu J; Lee JK; Shim YM
    Biochem Biophys Res Commun; 2011 Oct; 413(4):588-93. PubMed ID: 21925153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Integrative Transcriptomic and Metabolomic Study Revealed That Melatonin Plays a Protective Role in Chronic Lung Inflammation by Reducing Necroptosis.
    Mao K; Luo P; Geng W; Xu J; Liao Y; Zhong H; Ma P; Tan Q; Xia H; Duan L; Song S; Long D; Liu Y; Yang T; Wu Y; Jin Y
    Front Immunol; 2021; 12():668002. PubMed ID: 34017341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of histidine and energy homeostasis in chronic obstructive pulmonary disease.
    Diao W; Labaki WW; Han MK; Yeomans L; Sun Y; Smiley Z; Kim JH; McHugh C; Xiang P; Shen N; Sun X; Guo C; Lu M; Standiford TJ; He B; Stringer KA
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2015-2025. PubMed ID: 31564849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2 expression is increased in peripheral blood mononuclear cells derived from mild-moderate ex-smoker COPD patients with persistent oxidative stress.
    Fratta Pasini AM; Ferrari M; Stranieri C; Vallerio P; Mozzini C; Garbin U; Zambon G; Cominacini L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1733-43. PubMed ID: 27555763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood mononuclear cell gene expression in chronic obstructive pulmonary disease.
    Bahr TM; Hughes GJ; Armstrong M; Reisdorph R; Coldren CD; Edwards MG; Schnell C; Kedl R; LaFlamme DJ; Reisdorph N; Kechris KJ; Bowler RP
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):316-23. PubMed ID: 23590301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating 3-omics data analyze rat lung tissue of COPD states and medical intervention by delineation of molecular and pathway alterations.
    Li J; Zhao P; Yang L; Li Y; Tian Y; Li S; Bai Y
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28450497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomics and metabolomics revealed the pulmonary protective mechanism of Xixin-Ganjiang Herb Pair for warming the lungs to dissolve phlegm in COPD rats.
    Huang P; Duan B; Li D; Duan Y; Zhou Z; Han L; Li J; Wu J; Ye Y; Zhang F; Guo Z; Wang Q; Huang F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 May; 1224():123665. PubMed ID: 37209557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omics and the Search for Blood Biomarkers in Chronic Obstructive Pulmonary Disease. Insights from COPDGene.
    Regan EA; Hersh CP; Castaldi PJ; DeMeo DL; Silverman EK; Crapo JD; Bowler RP
    Am J Respir Cell Mol Biol; 2019 Aug; 61(2):143-149. PubMed ID: 30874442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of transcriptomics, proteomics, metabolomics and systems pharmacology data to reveal the therapeutic mechanism underlying Chinese herbal Bufei Yishen formula for the treatment of chronic obstructive pulmonary disease.
    Zhao P; Li J; Yang L; Li Y; Tian Y; Li S
    Mol Med Rep; 2018 Apr; 17(4):5247-5257. PubMed ID: 29393428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study.
    Calle Rubio M; Casamor R; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2373-2383. PubMed ID: 28848338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the severity of small airways obstruction and alveolar destruction in chronic obstructive pulmonary disease.
    Kawamoto T; Kanazawa H; Tochino Y; Kawaguchi T
    Respir Med; 2018 Aug; 141():159-164. PubMed ID: 30053962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-22 Defect During Streptococcus pneumoniae Infection Triggers Exacerbation of Chronic Obstructive Pulmonary Disease.
    Pichavant M; Sharan R; Le Rouzic O; Olivier C; Hennegrave F; Rémy G; Pérez-Cruz M; Koné B; Gosset P; Just N; Gosset P
    EBioMedicine; 2015 Nov; 2(11):1686-96. PubMed ID: 26870795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomics analysis identifies sex-associated metabotypes of oxidative stress and the autotaxin-lysoPA axis in COPD.
    Naz S; Kolmert J; Yang M; Reinke SN; Kamleh MA; Snowden S; Heyder T; Levänen B; Erle DJ; Sköld CM; Wheelock ÅM; Wheelock CE
    Eur Respir J; 2017 Jun; 49(6):. PubMed ID: 28642310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of proteomic signatures associated with COPD frequent exacerbators.
    Sun P; Ye R; Wang C; Bai S; Zhao L
    Life Sci; 2019 Aug; 230():1-9. PubMed ID: 31121174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary Artery Abnormalities in Ex-smokers with and without Airflow Obstruction.
    Lindenmaier TJ; Kirby M; Paulin G; Mielniczuk L; Cunningham IA; Mura M; Licskai C; Parraga G
    COPD; 2016; 13(2):224-34. PubMed ID: 26606693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.